Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
- 31 July 2011
- journal article
- research article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 46 (7), 3058-3065
- https://doi.org/10.1016/j.ejmech.2011.02.049
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Spectroscopic Studies of Ligand and Substrate Binding to Human Indoleamine 2,3-DioxygenaseBiochemistry, 2010
- Plectosphaeroic Acids A, B, and C, Indoleamine 2,3-Dioxygenase Inhibitors Produced in Culture by a Marine Isolate of the Fungus Plectosphaerella cucumerinaOrganic Letters, 2009
- Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-DioxygenaseJournal of Medicinal Chemistry, 2008
- Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer diseaseAmino Acids, 2008
- Virtual screening of chemical librariesNature, 2004
- Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 2004
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie, 1999
- Development and validation of a genetic algorithm for flexible dockingJournal of Molecular Biology, 1997
- Heme-Containing OxygenasesChemical Reviews, 1996
- Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-γ in human gyneocologic cancer cellsCancer Letters, 1992